Filtros : " IFSC111" "Universidade Federal do Rio Grande do Sul (UFRGS)" Removido: "2010" Limpar

Filtros



Refine with date range


  • Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidade: IFSC

    Subjects: CRISTALOGRAFIA, NEOPLASIAS MAMÁRIAS, METÁSTASE NEOPLÁSICA, FÁRMACOS

    PrivadoAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AFONSO, Maynara et al. Quinazoline-Chalcone hybrids as tubulin colchicine-binding site inhibitors for antimetastatic cancer drug discovery. 2024, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2024. Disponível em: https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/585_1708142139.pdf. Acesso em: 13 jun. 2024.
    • APA

      Afonso, M., Souza, M. da S., Mass, E., Russowsky, D., & Andricopulo, A. D. (2024). Quinazoline-Chalcone hybrids as tubulin colchicine-binding site inhibitors for antimetastatic cancer drug discovery. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/585_1708142139.pdf
    • NLM

      Afonso M, Souza M da S, Mass E, Russowsky D, Andricopulo AD. Quinazoline-Chalcone hybrids as tubulin colchicine-binding site inhibitors for antimetastatic cancer drug discovery [Internet]. Anais. 2024 ;[citado 2024 jun. 13 ] Available from: https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/585_1708142139.pdf
    • Vancouver

      Afonso M, Souza M da S, Mass E, Russowsky D, Andricopulo AD. Quinazoline-Chalcone hybrids as tubulin colchicine-binding site inhibitors for antimetastatic cancer drug discovery [Internet]. Anais. 2024 ;[citado 2024 jun. 13 ] Available from: https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/585_1708142139.pdf
  • Source: Organic Letters. Unidades: IFSC, IQSC

    Subjects: SOLUBILIDADE, ESPECTROSCOPIA, POLIMORFISMO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CÂMARA, Viktor Saraiva et al. Unveiling a strategy for ring opening of epoxides: synthesis of 2-hydroxyindolinylidenes using α-ester sulfoxonium ylides. Organic Letters, v. 26, n. Ja 2024, p. 1034-1039 + supporting information: 1-61, 2024Tradução . . Disponível em: https://doi.org/10.1021/acs.orglett.3c04169. Acesso em: 13 jun. 2024.
    • APA

      Câmara, V. S., Silva, A. L. da, Luz, L. C. da, Rodembusch, F. S., Santiago, P. H. de O., Ellena, J., & Burtoloso, A. C. B. (2024). Unveiling a strategy for ring opening of epoxides: synthesis of 2-hydroxyindolinylidenes using α-ester sulfoxonium ylides. Organic Letters, 26( Ja 2024), 1034-1039 + supporting information: 1-61. doi:10.1021/acs.orglett.3c04169
    • NLM

      Câmara VS, Silva AL da, Luz LC da, Rodembusch FS, Santiago PH de O, Ellena J, Burtoloso ACB. Unveiling a strategy for ring opening of epoxides: synthesis of 2-hydroxyindolinylidenes using α-ester sulfoxonium ylides [Internet]. Organic Letters. 2024 ; 26( Ja 2024): 1034-1039 + supporting information: 1-61.[citado 2024 jun. 13 ] Available from: https://doi.org/10.1021/acs.orglett.3c04169
    • Vancouver

      Câmara VS, Silva AL da, Luz LC da, Rodembusch FS, Santiago PH de O, Ellena J, Burtoloso ACB. Unveiling a strategy for ring opening of epoxides: synthesis of 2-hydroxyindolinylidenes using α-ester sulfoxonium ylides [Internet]. Organic Letters. 2024 ; 26( Ja 2024): 1034-1039 + supporting information: 1-61.[citado 2024 jun. 13 ] Available from: https://doi.org/10.1021/acs.orglett.3c04169
  • Source: European Journal of Medicinal Chemistry. Unidade: IFSC

    Subjects: RUTÊNIO, CITOTOXINAS, APOPTOSE

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GRAMINHA, Angelica E. et al. New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway. European Journal of Medicinal Chemistry, v. 243, p. 114772-1-114772-14 + supplementary data, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2022.114772. Acesso em: 13 jun. 2024.
    • APA

      Graminha, A. E., Popolin, C., Araujo Neto, J. H., Correa, R. S., Oliveira, K. M. de, Godoy, L. R., et al. (2022). New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway. European Journal of Medicinal Chemistry, 243, 114772-1-114772-14 + supplementary data. doi:10.1016/j.ejmech.2022.114772
    • NLM

      Graminha AE, Popolin C, Araujo Neto JH, Correa RS, Oliveira KM de, Godoy LR, Vegas LC, Ellena J, Batista AA, Cominetti MR. New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway [Internet]. European Journal of Medicinal Chemistry. 2022 ; 243 114772-1-114772-14 + supplementary data.[citado 2024 jun. 13 ] Available from: https://doi.org/10.1016/j.ejmech.2022.114772
    • Vancouver

      Graminha AE, Popolin C, Araujo Neto JH, Correa RS, Oliveira KM de, Godoy LR, Vegas LC, Ellena J, Batista AA, Cominetti MR. New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway [Internet]. European Journal of Medicinal Chemistry. 2022 ; 243 114772-1-114772-14 + supplementary data.[citado 2024 jun. 13 ] Available from: https://doi.org/10.1016/j.ejmech.2022.114772

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024